Healthcare Sector Stocks
The Healthcare sector has a total of 1055 stocks, with a combined market cap of $9.51 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.83.
Market Cap
9.51T
Revenue
4.67T
Profits
187.13B
PE Ratio
50.83
Profit Margin
4.01%
Dividend Yield
0.37%
1054 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | 0.01% | 2,447,003 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 663.23B | 1.48% | 7,912,744 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 462.49B | 0.67% | 4,225,289 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 374.12B | 1.19% | 8,969,364 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 358.73B | 0.85% | 3,266,706 | 450.53B |
| 6 | NVS | Novartis AG | 307.13B | 0.75% | 4,344,095 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 250.86B | -0.52% | 3,301,420 | 61.37B |
| 8 | AMGN | Amgen Inc. | 239.41B | 1.08% | 2,286,346 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 225.01B | 1.34% | 1,617,002 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 206.96B | 3.66% | 13,602,636 | 50.34B |
| 11 | ABT | Abbott Laboratories | 191.16B | 1.41% | 8,458,887 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 185.51B | -0.21% | 4,918,306 | 30.46B |
| 13 | PFE | Pfizer Inc. | 165.40B | 1.65% | 39,277,909 | 63.70B |
| 14 | DHR | Danaher Corporation | 147.56B | 1.44% | 2,951,051 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 141.11B | 1.66% | 1,734,767 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 138.21B | 1.11% | 7,825,452 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 131.38B | 0.71% | 2,053,478 | 11.03B |
| 18 | CVS | CVS Health Corporation | 124.35B | -0.38% | 5,403,635 | 412.65B |
| 19 | SYK | Stryker Corporation | 119.75B | -1.64% | 2,185,647 | 25.84B |
| 20 | MDT | Medtronic plc | 117.99B | 0.15% | 9,237,629 | 37.54B |
| 21 | MCK | McKesson Corporation | 107.82B | 1.99% | 856,565 | 410.98B |
| 22 | SNY | Sanofi | 107.16B | 0.23% | 2,170,243 | 55.89B |
| 23 | GSK | GSK plc | 100.74B | -0.43% | 2,938,430 | 44.05B |
| 24 | ELV | Elevance Health, Inc. | 88.01B | 0.69% | 980,904 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 87.05B | -2.79% | 1,534,978 | 78.01B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 85.08B | 3.42% | 749,253 | 15.53B |
| 27 | CI | The Cigna Group | 74.74B | -0.08% | 1,493,014 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 70.10B | 0.60% | 17,017,973 | 21.00B |
| 29 | ARGX | argenx SE | 65.29B | 2.61% | 216,974 | 5.32B |
| 30 | COR | Cencora, Inc. | 64.19B | 1.63% | 1,398,343 | 332.77B |
| 31 | MRNA | Moderna, Inc. | 60.21B | -2.24% | 16,562,890 | 2.23B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 58.62B | 1.10% | 1,721,817 | 28.42B |
| 33 | CAH | Cardinal Health, Inc. | 57.10B | 2.57% | 1,363,901 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.35B | 0.09% | 2,595,777 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.08B | 0.21% | 1,474,464 | 22.48B |
| 36 | HUM | Humana Inc. | 48.15B | 1.54% | 1,138,236 | 145.68B |
| 37 | MDLN | Medline Inc. | 47.72B | 3.39% | 9,701,021 | 29.94B |
| 38 | NTRA | Natera, Inc. | 46.87B | 1.37% | 1,032,919 | 2.71B |
| 39 | VEEV | Veeva Systems Inc. | 45.45B | 0.53% | 1,491,123 | 3.46B |
| 40 | RVMD | Revolution Medicines, Inc. | 44.85B | -0.30% | 1,333,392 | - |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 43.69B | 3.59% | 7,690,203 | 17.32B |
| 42 | HLN | Haleon plc | 43.54B | -1.59% | 10,528,402 | 14.80B |
| 43 | IQV | IQVIA Holdings Inc. | 43.43B | 2.13% | 1,127,933 | 16.98B |
| 44 | A | Agilent Technologies, Inc. | 42.68B | 0.97% | 3,130,819 | 7.37B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 42.46B | -1.13% | 655,523 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 41.14B | 0.87% | 295,201 | 6.13B |
| 47 | WAT | Waters Corporation | 40.50B | 1.57% | 621,465 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 36.29B | 1.27% | 3,143,697 | 2.54B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.78B | 8.65% | 3,270,512 | 4.80B |
| 50 | ALC | Alcon Inc. | 35.31B | 0.68% | 1,328,042 | 10.86B |
| 51 | DXCM | DexCom, Inc. | 33.85B | -0.50% | 1,917,606 | 4.97B |
| 52 | RMD | ResMed Inc. | 33.30B | -0.21% | 1,156,476 | 5.65B |
| 53 | CNC | Centene Corporation | 33.27B | 3.23% | 4,829,000 | 180.30B |
| 54 | BIIB | Biogen Inc. | 32.90B | 3.07% | 1,268,235 | 10.03B |
| 55 | ILMN | Illumina, Inc. | 32.20B | 2.95% | 1,771,940 | 4.49B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 31.87B | 0.20% | 2,067,700 | 21.27B |
| 57 | ZTS | Zoetis Inc. | 31.48B | -1.40% | 4,474,630 | 9.53B |
| 58 | INSM | Insmed Incorporated | 27.65B | 4.21% | 1,998,169 | 1.14B |
| 59 | MTD | Mettler-Toledo International Inc. | 27.40B | -0.60% | 178,966 | 4.13B |
| 60 | LH | Labcorp Holdings Inc. | 26.90B | 1.24% | 643,928 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.58B | 1.94% | 1,144,111 | 11.56B |
| 62 | INCY | Incyte Corporation | 26.11B | 3.06% | 2,324,073 | 5.82B |
| 63 | BNTX | BioNTech SE | 26.08B | 1.83% | 753,646 | 3.03B |
| 64 | PHG | Koninklijke Philips N.V. | 25.90B | -0.83% | 792,803 | 20.18B |
| 65 | ROIV | Roivant Sciences Ltd. | 24.69B | -0.98% | 6,179,252 | 7.53M |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.11B | 1.18% | 323,734 | 3.33B |
| 67 | STE | STERIS plc | 22.46B | 0.30% | 468,482 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 21.88B | -0.82% | 1,745,453 | 1.18B |
| 69 | UTHR | United Therapeutics Corporation | 21.10B | -4.03% | 1,404,125 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 20.82B | -2.75% | 1,046,827 | 21.81B |
| 71 | GMAB | Genmab A/S | 20.14B | 2.78% | 2,078,829 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.63B | 2.77% | 7,834,427 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.98B | 0.10% | 1,392,105 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.56B | 2.71% | 418,239 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.55B | 1.68% | 204,149 | 2.78B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.04B | 0.66% | 1,037,846 | 3.37B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.94B | 0.76% | 1,155,945 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.64B | 1.04% | 826,104 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.96B | -0.09% | 1,620,635 | 713.07M |
| 80 | RVTY | Revvity, Inc. | 14.61B | 3.44% | 2,101,523 | 2.91B |
| 81 | EXEL | Exelixis, Inc. | 14.50B | 2.88% | 2,849,874 | 2.44B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.93B | 3.34% | 606,454 | 4.00B |
| 83 | COO | The Cooper Companies, Inc. | 13.60B | 0.66% | 1,582,595 | 4.23B |
| 84 | BAX | Baxter International Inc. | 13.29B | 0.86% | 4,167,850 | 11.47B |
| 85 | BMRN | BioMarin Pharmaceutical Inc. | 12.96B | 3.29% | 2,521,257 | 3.41B |
| 86 | PEN | Penumbra, Inc. | 12.71B | 0.07% | 220,277 | 1.50B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.64B | 1.53% | 202,800 | 1.28B |
| 88 | BTSG | BrightSpring Health Services, Inc. | 12.55B | 1.84% | 1,767,237 | 14.37B |
| 89 | HALO | Halozyme Therapeutics, Inc. | 12.45B | 1.80% | 1,619,428 | 1.66B |
| 90 | ICLR | ICON Public Limited Company | 12.33B | -0.97% | 893,167 | 8.29B |
| 91 | ELAN | Elanco Animal Health Incorporated | 12.33B | 3.22% | 6,741,597 | 5.02B |
| 92 | FMS | Fresenius Medical Care AG | 12.09B | -0.40% | 646,530 | 22.19B |
| 93 | SNN | Smith & Nephew plc | 12.07B | -1.07% | 4,794,086 | 6.30B |
| 94 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.06B | 3.18% | 1,525,564 | 669.50M |
| 95 | EHC | Encompass Health Corporation | 11.95B | -0.71% | 650,838 | 6.21B |
| 96 | CORT | Corcept Therapeutics Incorporated | 11.94B | -2.60% | 960,050 | 830.81M |
| 97 | SMMT | Summit Therapeutics Inc. | 11.65B | 3.11% | 3,779,231 | - |
| 98 | DVA | DaVita Inc. | 11.44B | 1.85% | 513,495 | 14.01B |
| 99 | TECH | Bio-Techne Corporation | 11.34B | 0.17% | 1,646,337 | 1.22B |
| 100 | ALGN | Align Technology, Inc. | 11.31B | 2.70% | 687,054 | 4.14B |
| 101 | TEM | Tempus AI, Inc. | 11.18B | -0.53% | 5,785,677 | 1.43B |
| 102 | AXSM | Axsome Therapeutics, Inc. | 11.00B | 3.50% | 608,119 | 776.57M |
| 103 | KRYS | Krystal Biotech, Inc. | 10.93B | 1.48% | 305,179 | 440.48M |
| 104 | GMED | Globus Medical, Inc. | 10.83B | 0.22% | 826,117 | 3.14B |
| 105 | GKOS | Glaukos Corporation | 10.58B | 1.60% | 768,717 | 612.84M |
| 106 | MOH | Molina Healthcare, Inc. | 10.55B | -0.22% | 463,776 | 42.47B |
| 107 | ABVX | ABIVAX Société Anonyme | 10.48B | -2.28% | 868,276 | 5.67M |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.39B | 1.98% | 285,331 | 2.59B |
| 109 | PODD | Insulet Corporation | 10.27B | -0.16% | 1,113,945 | 3.05B |
| 110 | RDY | Dr. Reddy's Laboratories Limited | 10.24B | - | 4,010,240 | 3.50B |
| 111 | IONS | Ionis Pharmaceuticals, Inc. | 10.19B | 2.42% | 1,845,861 | 874.09M |
| 112 | APGE | Apogee Therapeutics, Inc. | 10.19B | -0.01% | 5,142,068 | - |
| 113 | HSIC | Henry Schein, Inc. | 10.07B | 2.11% | 859,381 | 13.60B |
| 114 | CYTK | Cytokinetics, Incorporated | 10.00B | 0.74% | 1,605,336 | 67.67M |
| 115 | PRAX | Praxis Precision Medicines, Inc. | 9.98B | 1.15% | 289,358 | 7.46M |
| 116 | ENSG | The Ensign Group, Inc. | 9.98B | -0.29% | 220,241 | 5.49B |
| 117 | AVTR | Avantor, Inc. | 9.91B | 3.17% | 8,922,059 | 6.56B |
| 118 | UHS | Universal Health Services, Inc. | 9.87B | -1.91% | 808,881 | 18.11B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 9.86B | -0.35% | 982,952 | 105.00M |
| 120 | RGEN | Repligen Corporation | 9.76B | 1.72% | 959,253 | 785.10M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.45B | -0.28% | 561,501 | 281.99M |
| 122 | OSCR | Oscar Health, Inc. | 9.35B | 1.68% | 4,579,914 | 15.32B |
| 123 | PCVX | Vaxcyte, Inc. | 9.16B | 1.27% | 1,021,230 | - |
| 124 | QGEN | Qiagen N.V. | 9.14B | 1.87% | 2,198,751 | 2.10B |
| 125 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.01B | - | - | 42.16M |
| 126 | BRKR | Bruker Corporation | 8.99B | 5.34% | 1,899,631 | 3.50B |
| 127 | IBRX | ImmunityBio, Inc. | 8.43B | 1.02% | 7,228,321 | 165.79M |
| 128 | ATR | AptarGroup, Inc. | 8.29B | -0.45% | 472,479 | 3.93B |
| 129 | TWST | Twist Bioscience Corporation | 8.21B | -0.80% | 1,900,198 | 431.80M |
| 130 | IMVT | Immunovant, Inc. | 8.16B | -1.03% | 1,331,002 | - |
| 131 | HQY | HealthEquity, Inc. | 8.15B | 1.59% | 784,523 | 1.36B |
| 132 | TGTX | TG Therapeutics, Inc. | 8.07B | 1.44% | 2,361,895 | 799.54M |
| 133 | TXG | 10x Genomics, Inc. | 8.03B | 2.78% | 1,604,980 | 616.91M |
| 134 | ALKS | Alkermes plc | 8.01B | 1.10% | 1,566,410 | 1.67B |
| 135 | SYRE | Spyre Therapeutics, Inc. | 7.68B | -1.64% | 1,361,505 | - |
| 136 | HNGE | Hinge Health, Inc. | 7.41B | 2.03% | 2,540,622 | 720.06M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.26B | 0.65% | 455,568 | 239.92M |
| 138 | CAI | Caris Life Sciences, Inc. | 7.01B | 0.08% | 5,488,319 | 989.61M |
| 139 | GRFS | Grifols, S.A. | 6.87B | 1.29% | 174,120 | 8.48B |
| 140 | SRRK | Scholar Rock Holding Corporation | 6.83B | 0.38% | 1,065,936 | - |
| 141 | PACS | PACS Group, Inc. | 6.82B | 2.25% | 651,190 | 5.55B |
| 142 | CHE | Chemed Corporation | 6.82B | 1.71% | 129,965 | 2.60B |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.69B | 0.84% | 7,900,948 | 2.58B |
| 144 | MMED | MiniMed Group, Inc. | 6.67B | 5.98% | 4,491,445 | 3.22B |
| 145 | CGON | CG Oncology, Inc. | 6.61B | -1.67% | 663,523 | 6.23M |
| 146 | LNTH | Lantheus Holdings, Inc. | 6.58B | -0.07% | 750,636 | 1.56B |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.48B | 1.52% | 495,626 | 618.07M |
| 148 | BLTE | Belite Bio, Inc | 6.47B | 2.53% | 212,681 | - |
| 149 | BLCO | Bausch + Lomb Corporation | 6.43B | 0.67% | 358,602 | 5.32B |
| 150 | TVTX | Travere Therapeutics, Inc. | 6.34B | 2.31% | 1,085,737 | 591.33M |
| 151 | AMRX | Amneal Pharmaceuticals, Inc. | 6.29B | 2.15% | 2,607,649 | 3.12B |
| 152 | LQDA | Liquidia Corporation | 6.24B | 4.14% | 1,282,312 | 450.91M |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.23B | 0.77% | 568,415 | 840.85M |
| 154 | ORKA | Oruka Therapeutics, Inc. | 6.07B | -0.52% | 672,156 | - |
| 155 | COGT | Cogent Biosciences, Inc. | 6.00B | -0.32% | 1,181,436 | - |
| 156 | PTCT | PTC Therapeutics, Inc. | 5.99B | 1.74% | 902,560 | 1.01B |
| 157 | TFX | Teleflex Incorporated | 5.97B | 0.35% | 728,069 | 2.25B |
| 158 | RDNT | RadNet, Inc. | 5.96B | 0.24% | 712,712 | 2.27B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.94B | -0.36% | 563,454 | 1.90M |
| 160 | XENE | Xenon Pharmaceuticals Inc. | 5.83B | 0.27% | 637,186 | 7.50M |
| 161 | ERAS | Erasca, Inc. | 5.73B | -2.33% | 5,119,502 | - |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 5.72B | 0.93% | 189,544 | 290.54M |
| 163 | STVN | Stevanato Group S.p.A. | 5.66B | 0.10% | 217,192 | 1.40B |
| 164 | CRSP | CRISPR Therapeutics AG | 5.50B | 0.18% | 908,939 | 13.39M |
| 165 | SHC | Sotera Health Company | 5.41B | 1.50% | 1,460,161 | 1.22B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.38B | -0.61% | 810,497 | 1.58B |
| 167 | DFTX | Definium Therapeutics, Inc. | 5.23B | 1.04% | 1,423,372 | - |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.98B | 0.14% | 1,555,973 | 1.14B |
| 169 | PBLS | Parabilis Medicines, Inc. | 4.95B | 1.62% | 363,933 | 148.00K |
| 170 | WAY | Waystar Holding Corp. | 4.93B | -0.16% | 1,645,077 | 1.21B |
| 171 | LFST | LifeStance Health Group, Inc. | 4.92B | 2.30% | 3,255,683 | 1.58B |
| 172 | CELC | Celcuity Inc. | 4.71B | 4.59% | 819,181 | - |
| 173 | DYN | Dyne Therapeutics, Inc. | 4.69B | 0.16% | 2,178,828 | - |
| 174 | DOCS | Doximity, Inc. | 4.69B | -0.11% | 1,977,343 | 655.57M |
| 175 | HAE | Haemonetics Corporation | 4.68B | 0.95% | 777,669 | 1.35B |
| 176 | EWTX | Edgewise Therapeutics, Inc. | 4.56B | -0.64% | 1,002,920 | - |
| 177 | LIVN | LivaNova PLC | 4.54B | 2.79% | 659,947 | 1.47B |
| 178 | BLLN | BillionToOne, Inc. | 4.54B | 4.15% | 414,785 | 397.41M |
| 179 | NVST | Envista Holdings Corporation | 4.40B | 2.82% | 1,758,083 | 2.86B |
| 180 | HTFL | HeartFlow, Inc. | 4.35B | -0.85% | 1,752,288 | 212.07M |
| 181 | CON | Concentra Group Holdings Parent, Inc. | 4.34B | 0.41% | 658,436 | 2.29B |
| 182 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.33B | 2.01% | 1,938,252 | -665.00K |
| 183 | ELVN | Enliven Therapeutics, Inc. | 4.32B | 1.99% | 608,144 | - |
| 184 | ITGR | Integer Holdings Corporation | 4.26B | -0.06% | 642,063 | 1.84B |
| 185 | ICUI | ICU Medical, Inc. | 4.25B | -0.56% | 357,292 | 2.16B |
| 186 | LEGN | Legend Biotech Corporation | 4.24B | 3.60% | 1,478,958 | 1.27B |
| 187 | INDV | Indivior Pharmaceuticals, Inc. | 4.14B | 1.42% | 2,974,421 | 1.33B |
| 188 | MANE | Veradermics, Incorporated | 4.11B | 0.97% | 427,289 | - |
| 189 | RLAY | Relay Therapeutics, Inc. | 4.06B | 0.11% | 2,107,870 | 10.35M |
| 190 | IRTC | iRhythm Holdings, Inc. | 4.04B | 0.11% | 338,406 | 825.34M |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 3.94B | 1.31% | 1,623,116 | 308.08M |
| 192 | VKTX | Viking Therapeutics, Inc. | 3.91B | -0.50% | 1,573,315 | - |
| 193 | IOVA | Iovance Biotherapeutics, Inc. | 3.90B | 4.11% | 12,393,150 | 324.97M |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.88B | 0.55% | 765,283 | 234.13M |
| 195 | TLX | Telix Pharmaceuticals Limited | 3.82B | 5.53% | 239,366 | 890.79M |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.80B | 0.47% | 1,233,681 | 117.00M |
| 197 | TNGX | Tango Therapeutics, Inc. | 3.76B | -0.13% | 1,916,704 | 53.81M |
| 198 | PLSE | Pulse Biosciences, Inc. | 3.76B | 1.13% | 977,971 | 1.19M |
| 199 | ABCL | AbCellera Biologics Inc. | 3.68B | 0.71% | 3,726,310 | 66.17M |
| 200 | DNLI | Denali Therapeutics Inc. | 3.65B | -1.78% | 1,767,400 | 3.60M |
| 201 | TARS | Tarsus Pharmaceuticals, Inc. | 3.63B | 11.76% | 1,899,846 | 606.33M |
| 202 | OGN | Organon & Co. | 3.62B | 0.07% | 3,626,154 | 6.13B |
| 203 | VCYT | Veracyte, Inc. | 3.61B | 3.34% | 1,357,584 | 561.90M |
| 204 | GRAL | GRAIL, Inc. | 3.60B | 0.97% | 449,183 | 165.26M |
| 205 | OPCH | Option Care Health, Inc. | 3.57B | 0.89% | 1,294,228 | 5.69B |
| 206 | GPCR | Structure Therapeutics Inc. | 3.41B | 1.42% | 1,064,737 | - |
| 207 | NHC | National HealthCare Corporation | 3.40B | -0.74% | 117,525 | 1.56B |
| 208 | QURE | uniQure N.V. | 3.21B | -3.41% | 2,485,970 | 18.67M |
| 209 | RGC | Regencell Bioscience Holdings Limited | 3.13B | 14.73% | 373,685 | - |
| 210 | IMNM | Immunome, Inc. | 3.10B | 0.96% | 811,061 | 4.02M |
| 211 | CLDX | Celldex Therapeutics, Inc. | 3.10B | 0.61% | 476,517 | 158.00K |
| 212 | IRON | Disc Medicine, Inc. | 3.07B | 1.75% | 522,539 | - |
| 213 | NAMS | NewAmsterdam Pharma Company N.V. | 3.06B | 2.69% | 979,901 | 7.12M |
| 214 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | 0.42% | 1,950,713 | 463.98M |
| 215 | ZLAB | Zai Lab Limited | 2.97B | 4.66% | 1,056,763 | 449.61M |
| 216 | WRBY | Warby Parker Inc. | 2.96B | -1.16% | 1,975,463 | 911.61M |
| 217 | MBX | MBX Biosciences, Inc. | 2.93B | -0.07% | 352,267 | - |
| 218 | BEAM | Beam Therapeutics Inc. | 2.93B | 0.93% | 1,293,345 | 156.04M |
| 219 | TMDX | TransMedics Group, Inc. | 2.92B | 2.49% | 589,831 | 668.47M |
| 220 | AVAH | Aveanna Healthcare Holdings Inc. | 2.88B | -1.93% | 1,882,529 | 2.60B |
| 221 | SLS | SELLAS Life Sciences Group, Inc. | 2.86B | 7.11% | 6,236,312 | - |
| 222 | BKD | Brookdale Senior Living Inc. | 2.85B | 0.17% | 3,515,488 | 2.93B |
| 223 | ALHC | Alignment Healthcare, Inc. | 2.82B | - | 3,631,035 | 4.58B |
| 224 | ATAI | AtaiBeckley Inc. | 2.73B | 0.14% | 10,454,899 | 4.47M |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.68B | -0.84% | 1,736,079 | 36.77M |
| 226 | ATRC | AtriCure, Inc. | 2.68B | 7.50% | 1,262,477 | 569.62M |
| 227 | PRVA | Privia Health Group, Inc. | 2.65B | 0.39% | 1,200,880 | 2.36B |
| 228 | RARE | Ultragenyx Pharmaceutical Inc. | 2.61B | 2.79% | 7,170,810 | 717.00M |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.60B | 2.52% | 3,130,174 | 940.61M |
| 230 | AXGN | Axogen, Inc. | 2.60B | -3.17% | 789,915 | 251.17M |
| 231 | WGS | GeneDx Holdings Corp. | 2.59B | 2.25% | 500,104 | 454.43M |
| 232 | ACHC | Acadia Healthcare Company, Inc. | 2.58B | -1.77% | 1,138,397 | 3.37B |
| 233 | VRDN | Viridian Therapeutics, Inc. | 2.58B | -1.09% | 1,417,441 | 71.13M |
| 234 | NEOG | Neogen Corporation | 2.58B | 1.46% | 2,179,780 | 870.40M |
| 235 | VERA | Vera Therapeutics, Inc. | 2.57B | 4.18% | 1,756,865 | - |
| 236 | MLYS | Mineralys Therapeutics, Inc. | 2.57B | 13.57% | 2,039,901 | - |
| 237 | CDNA | CareDx, Inc. | 2.57B | 1.29% | 826,209 | 458.09M |
| 238 | SUPN | Supernus Pharmaceuticals, Inc. | 2.56B | 0.66% | 445,920 | 830.44M |
| 239 | BHC | Bausch Health Companies Inc. | 2.55B | 5.56% | 7,721,005 | 10.85B |
| 240 | PGEN | Precigen, Inc. | 2.51B | 2.19% | 2,637,473 | 85.72M |
| 241 | PBH | Prestige Consumer Healthcare Inc. | 2.50B | 0.36% | 440,012 | 1.10B |
| 242 | HRMY | Harmony Biosciences Holdings, Inc. | 2.50B | 3.90% | 1,111,960 | 959.90M |
| 243 | NKTR | Nektar Therapeutics | 2.48B | 1.38% | 353,956 | 54.59M |
| 244 | GRDN | Guardian Pharmacy Services, Inc. | 2.47B | 0.44% | 469,723 | 1.46B |
| 245 | PHVS | Pharvaris N.V. | 2.47B | 0.69% | 320,876 | - |
| 246 | SRPT | Sarepta Therapeutics, Inc. | 2.45B | 8.81% | 4,807,157 | 1.97B |
| 247 | NUVB | Nuvation Bio Inc. | 2.43B | 4.37% | 4,997,640 | 169.90M |
| 248 | TRVI | Trevi Therapeutics, Inc. | 2.43B | 2.90% | 1,350,068 | - |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.39B | 3.12% | 2,068,790 | 52.06M |
| 250 | BHVN | Biohaven Ltd. | 2.37B | -0.32% | 2,679,468 | - |
| 251 | KOD | Kodiak Sciences Inc. | 2.35B | 1.19% | 507,373 | - |
| 252 | RAPP | Rapport Therapeutics, Inc. | 2.34B | 0.27% | 294,650 | 20.00M |
| 253 | CLOV | Clover Health Investments, Corp. | 2.28B | - | 3,321,830 | 2.48B |
| 254 | UFPT | UFP Technologies, Inc. | 2.27B | -0.55% | 119,727 | 631.64M |
| 255 | TRLV | Trulieve Cannabis Corp. | 2.25B | -0.43% | 1,972,631 | 1.14B |
| 256 | XRAY | DENTSPLY SIRONA Inc. | 2.25B | 4.93% | 4,607,499 | 3.64B |
| 257 | NEO | NeoGenomics, Inc. | 2.24B | -0.29% | 1,794,474 | 766.30M |
| 258 | ESTA | Establishment Labs Holdings Inc. | 2.23B | 7.72% | 577,259 | 245.82M |
| 259 | MESO | Mesoblast Limited | 2.21B | 4.61% | 158,669 | 120.25M |
| 260 | PVLA | Palvella Therapeutics, Inc. | 2.20B | 1.59% | 125,221 | - |
| 261 | ZYME | Zymeworks Inc. | 2.20B | 4.65% | 808,053 | 37.13M |
| 262 | URGN | UroGen Pharma Ltd. | 2.17B | 2.37% | 473,497 | 188.73M |
| 263 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | 1.50% | 842,378 | 311.51M |
| 264 | ADUS | Addus HomeCare Corporation | 2.16B | 3.16% | 292,066 | 1.48B |
| 265 | ZBIO | Zenas BioPharma, Inc. | 2.16B | 3.60% | 757,450 | 1.00M |
| 266 | MD | Pediatrix Medical Group, Inc. | 2.13B | 1.47% | 823,720 | 1.95B |
| 267 | ADMA | ADMA Biologics, Inc. | 2.13B | 1.93% | 1,989,634 | 512.28M |
| 268 | ALMR | Alamar Biosciences, Inc. | 2.12B | 3.92% | 241,144 | 100.42M |
| 269 | HCM | HUTCHMED (China) Limited | 2.11B | 1.09% | 62,245 | 549.12M |
| 270 | VCEL | Vericel Corporation | 2.09B | 0.96% | 395,515 | 306.30M |
| 271 | GENB | Generate Biomedicines, Inc. | 2.09B | 3.10% | 892,502 | 26.48M |
| 272 | COAG | Hemab Therapeutics Holdings, Inc. | 2.09B | 1.61% | 325,207 | - |
| 273 | NVCR | NovoCure Limited | 2.08B | 2.70% | 1,324,034 | 699.19M |
| 274 | NBTX | Nanobiotix S.A. | 2.07B | 6.06% | 185,253 | 38.27M |
| 275 | KLRA | Kailera Therapeutics, Inc. | 2.05B | -3.41% | 737,207 | - |
| 276 | KARD | Kardigan, Inc. | 2.05B | 11.84% | 354,919 | - |
| 277 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | -0.23% | 650,842 | 98.34M |
| 278 | BFLY | Butterfly Network, Inc. | 2.02B | -7.09% | 5,347,942 | 112.14M |
| 279 | PGNY | Progyny, Inc. | 2.02B | 2.46% | 1,025,196 | 1.31B |
| 280 | PRGO | Perrigo Company plc | 2.01B | 0.42% | 2,687,016 | 4.14B |
| 281 | XNCR | Xencor, Inc. | 2.00B | -3.62% | 1,018,290 | 104.97M |
| 282 | ASTH | Astrana Health, Inc. | 1.97B | -0.08% | 305,456 | 3.84B |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.97B | -1.26% | 630,764 | 27.59M |
| 284 | VIR | Vir Biotechnology, Inc. | 1.95B | -1.12% | 3,019,777 | 303.23M |
| 285 | GHRS | GH Research PLC | 1.93B | 2.60% | 111,840 | - |
| 286 | IMCR | Immunocore Holdings plc | 1.92B | 1.38% | 220,688 | 430.78M |
| 287 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.92B | 1.10% | 3,668,981 | 208.78M |
| 288 | ALVO | Alvotech | 1.91B | 1.91% | 699,846 | 494.61M |
| 289 | SLBT | SL Science Holding Limited | 1.89B | 18.64% | 116,615 | 3.27M |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 0.91% | 215,154 | 1.13B |
| 291 | LMAT | LeMaitre Vascular, Inc. | 1.87B | 0.79% | 248,171 | 262.43M |
| 292 | SNDX | Syndax Pharmaceuticals, Inc. | 1.86B | 3.38% | 2,016,195 | 252.25M |
| 293 | INBX | Inhibrx Biosciences, Inc. | 1.84B | 0.25% | 189,885 | 1.30M |
| 294 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | -1.05% | 1,988,567 | 5.49M |
| 295 | CMPS | COMPASS Pathways plc | 1.83B | -0.08% | 1,925,618 | - |
| 296 | INSP | Inspire Medical Systems, Inc. | 1.82B | 2.52% | 413,004 | 898.74M |
| 297 | SGRY | Surgery Partners, Inc. | 1.81B | -4.25% | 2,212,871 | 3.37B |
| 298 | RXRX | Recursion Pharmaceuticals, Inc. | 1.81B | 1.50% | 14,052,683 | 54.86M |
| 299 | NTLA | Intellia Therapeutics, Inc. | 1.79B | 0.55% | 3,245,332 | 59.51M |
| 300 | PSNL | Personalis, Inc. | 1.79B | -1.93% | 2,227,162 | 69.67M |
| 301 | SNDA | Sonida Senior Living, Inc. | 1.78B | -0.58% | 443,095 | 481.07M |
| 302 | ETON | Eton Pharmaceuticals, Inc. | 1.77B | 2.53% | 510,138 | 105.60M |
| 303 | BLFS | BioLife Solutions, Inc. | 1.76B | 1.27% | 967,461 | 106.69M |
| 304 | SEPN | Septerna, Inc. | 1.75B | -0.48% | 263,215 | 98.88M |
| 305 | FTRE | Fortrea Holdings Inc. | 1.75B | 3.61% | 902,414 | 2.68B |
| 306 | DMRA | Damora Therapeutics, Inc. | 1.74B | 0.14% | 462,237 | - |
| 307 | BRVE | Braveheart Bio, Inc. | 1.73B | 2.55% | 394,468 | - |
| 308 | FRNM | Freenome, Inc. | 1.71B | 4.59% | 985,226 | 35.41M |
| 309 | NVAX | Novavax, Inc. | 1.70B | 1.98% | 5,635,819 | 413.80M |
| 310 | ANAB | AnaptysBio, Inc. | 1.65B | 1.09% | 421,726 | 232.39M |
| 311 | PAHC | Phibro Animal Health Corporation | 1.62B | 4.04% | 246,706 | 1.52B |
| 312 | TRAX | First Tracks Biotherapeutics, Inc. | 1.62B | 9.98% | 1,365,068 | - |
| 313 | LBRX | LB Pharmaceuticals Inc | 1.60B | 5.05% | 518,386 | - |
| 314 | OMCL | Omnicell, Inc. | 1.58B | 0.58% | 634,457 | 1.25B |
| 315 | AVLN | Avalyn Pharma Inc. | 1.58B | 0.85% | 181,850 | - |
| 316 | ANIP | ANI Pharmaceuticals, Inc. | 1.57B | 1.59% | 287,597 | 978.38M |
| 317 | XERS | Xeris Biopharma Holdings, Inc. | 1.56B | 1.78% | 1,350,791 | 335.41M |
| 318 | SDGR | Schrödinger, Inc. | 1.56B | 0.19% | 1,234,161 | 259.04M |
| 319 | BCAX | Bicara Therapeutics Inc. | 1.56B | 0.60% | 518,792 | - |
| 320 | INVA | Innoviva, Inc. | 1.54B | 1.28% | 600,536 | 440.00M |
| 321 | APMD | Apnimed, Inc. | 1.54B | 3.65% | 276,551 | 120.15M |
| 322 | ARDT | Ardent Health, Inc. | 1.54B | -0.27% | 527,205 | 6.41B |
| 323 | AAPG | Ascentage Pharma Group International | 1.53B | 4.74% | 2,480 | 94.61M |
| 324 | ABSI | Absci Corporation | 1.51B | -0.45% | 2,951,546 | 1.56M |
| 325 | KMTS | Kestra Medical Technologies, Ltd. | 1.51B | 2.43% | 245,527 | 95.13M |
| 326 | REPL | Replimune Group, Inc. | 1.51B | 1.98% | 1,989,590 | - |
| 327 | AVBP | ArriVent BioPharma, Inc. | 1.50B | 1.19% | 423,864 | - |
| 328 | TYRA | Tyra Biosciences, Inc. | 1.50B | -0.67% | 567,884 | - |
| 329 | AKTS | Aktis Oncology, Inc. | 1.50B | 3.58% | 253,396 | 10.06M |
| 330 | HCSG | Healthcare Services Group, Inc. | 1.49B | -0.23% | 558,451 | 1.86B |
| 331 | MAZE | Maze Therapeutics, Inc. | 1.48B | 0.72% | 440,553 | 20.00M |
| 332 | CNMD | CONMED Corporation | 1.48B | 0.63% | 299,262 | 1.37B |
| 333 | INNV | InnovAge Holding Corp. | 1.47B | -0.18% | 232,438 | 949.17M |
| 334 | AGL | agilon health, inc. | 1.47B | -0.10% | 178,656 | 5.92B |
| 335 | VOR | Vor Biopharma Inc. | 1.46B | 9.36% | 824,984 | - |
| 336 | HROW | Harrow, Inc. | 1.46B | 5.63% | 470,454 | 275.59M |
| 337 | ANRO | Alto Neuroscience, Inc. | 1.44B | 4.09% | 432,775 | - |
| 338 | CGEM | Cullinan Therapeutics, Inc. | 1.44B | 2.48% | 767,942 | - |
| 339 | TNDM | Tandem Diabetes Care, Inc. | 1.43B | -3.38% | 1,136,327 | 1.04B |
| 340 | OMDA | Omada Health, Inc. | 1.43B | 2.06% | 1,053,373 | 309.76M |
| 341 | ATEC | Alphatec Holdings, Inc. | 1.42B | -0.22% | 1,435,235 | 815.05M |
| 342 | AZTA | Azenta, Inc. | 1.39B | 0.51% | 792,703 | 613.81M |
| 343 | SVRA | Savara Inc. | 1.39B | 2.06% | 1,216,845 | - |
| 344 | LTGO | Latigo Biotherapeutics, Inc. | 1.38B | -2.20% | 163,207 | - |
| 345 | OMER | Omeros Corporation | 1.37B | 0.59% | 1,350,615 | 38.42M |
| 346 | JBIO | Jade Biosciences, Inc. | 1.36B | 1.81% | 506,153 | - |
| 347 | ORIC | ORIC Pharmaceuticals, Inc. | 1.36B | 1.86% | 1,546,221 | - |
| 348 | MGTX | MeiraGTx Holdings plc | 1.35B | -0.92% | 629,371 | 397.50M |
| 349 | ALMS | Alumis Inc. | 1.34B | 9.29% | 10,382,833 | 7.40M |
| 350 | SPTX | Seaport Therapeutics, Inc. | 1.33B | 5.38% | 156,426 | - |
| 351 | DRTS | Alpha Tau Medical Ltd. | 1.32B | 2.65% | 372,144 | - |
| 352 | PNTG | The Pennant Group, Inc. | 1.32B | 0.32% | 208,406 | 1.10B |
| 353 | NUTX | Nutex Health Inc. | 1.31B | 2.49% | 135,737 | 846.72M |
| 354 | IART | Integra LifeSciences Holdings Corporation | 1.31B | 1.14% | 528,824 | 1.65B |
| 355 | MNKD | MannKind Corporation | 1.30B | 1.51% | 2,590,705 | 393.63M |
| 356 | IMTX | Immatics N.V. | 1.30B | 0.74% | 761,069 | 47.65M |
| 357 | AMN | AMN Healthcare Services, Inc. | 1.29B | -0.48% | 480,277 | 3.43B |
| 358 | AORT | Artivion, Inc. | 1.28B | -2.77% | 549,492 | 471.47M |
| 359 | MLTX | MoonLake Immunotherapeutics | 1.28B | -0.46% | 1,187,492 | - |
| 360 | ODTX | Odyssey Therapeutics, Inc. | 1.28B | 8.65% | 171,403 | 99.00K |
| 361 | CERT | Certara, Inc. | 1.26B | 2.22% | 1,525,299 | 421.75M |
| 362 | OPK | OPKO Health, Inc. | 1.26B | 11.18% | 7,144,330 | 587.90M |
| 363 | PRCT | PROCEPT BioRobotics Corporation | 1.26B | 5.07% | 1,277,723 | 337.34M |
| 364 | CRON | Cronos Group Inc. | 1.24B | -4.14% | 854,951 | 179.09M |
| 365 | GLUE | Monte Rosa Therapeutics, Inc. | 1.21B | -0.63% | 1,529,812 | 28.73M |
| 366 | BVS | Bioventus Inc. | 1.21B | 5.12% | 668,280 | 581.85M |
| 367 | JANX | Janux Therapeutics, Inc. | 1.20B | 4.29% | 1,525,615 | 24.00M |
| 368 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -0.49% | 618,932 | - |
| 369 | GDRX | GoodRx Holdings, Inc. | 1.18B | -0.29% | 1,298,472 | 785.23M |
| 370 | TDOC | Teladoc Health, Inc. | 1.17B | 3.19% | 3,898,328 | 2.49B |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.17B | 0.63% | 100,065 | 804.27M |
| 372 | KURA | Kura Oncology, Inc. | 1.17B | 1.71% | 1,884,832 | 77.23M |
| 373 | ENOV | Enovis Corporation | 1.16B | -1.61% | 2,475,000 | 2.30B |
| 374 | SANA | Sana Biotechnology, Inc. | 1.16B | 1.57% | 2,140,796 | - |
| 375 | STAA | STAAR Surgical Company | 1.16B | -1.74% | 472,783 | 339.59M |
| 376 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | 0.95% | 237,741 | 1.04B |
| 377 | IVA | Inventiva S.A. | 1.12B | 1.89% | 810,610 | 7.94M |
| 378 | IRMD | IRADIMED CORPORATION | 1.10B | -0.14% | 96,021 | 86.34M |
| 379 | SLDB | Solid Biosciences Inc. | 1.10B | 4.10% | 894,265 | - |
| 380 | PCRX | Pacira BioSciences, Inc. | 1.06B | 0.42% | 610,787 | 746.16M |
| 381 | OBX | Obsidian Therapeutics, Inc. | 1.05B | -0.23% | 126,266 | - |
| 382 | AVTX | Avalo Therapeutics, Inc. | 1.04B | 2.06% | 987,856 | 59.00K |
| 383 | GERN | Geron Corporation | 1.02B | 7.43% | 26,889,923 | 204.56M |
| 384 | CSTL | Castle Biosciences, Inc. | 1.02B | -0.06% | 199,816 | 357.28M |
| 385 | FTH | Faeth Therapeutics, Inc. | 1.01B | 13.36% | 575,042 | - |
| 386 | CADL | Candel Therapeutics, Inc. | 1.01B | 2.72% | 807,791 | - |
| 387 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.01B | 3.40% | 456,755 | 730.02M |
| 388 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.20% | 2,975,649 | 181.72M |
| 389 | IMMX | Immix Biopharma, Inc. | 998.69M | -0.36% | 1,578,203 | - |
| 390 | LXRX | Lexicon Pharmaceuticals, Inc. | 996.70M | 2.28% | 2,335,858 | 41.47M |
| 391 | ATTO | Attovia Therapeutics, Inc. | 995.26M | 4.10% | 81,412 | 1.35M |
| 392 | GMRS | GMR Solutions Inc. | 994.06M | -1.39% | 470,454 | 5.88B |
| 393 | DSGN | Design Therapeutics, Inc. | 971.89M | 2.58% | 1,002,976 | - |
| 394 | WVE | Wave Life Sciences, Inc. | 961.60M | -1.81% | 5,479,190 | 65.37M |
| 395 | QDEL | QuidelOrtho Corporation | 956.63M | 1.45% | 834,459 | 2.67B |
| 396 | CBLL | CeriBell, Inc. | 952.16M | 0.94% | 502,801 | 101.96M |
| 397 | OLMA | Olema Pharmaceuticals, Inc. | 947.60M | 2.56% | 866,407 | - |
| 398 | SGP | SpyGlass Pharma, Inc. | 947.08M | 5.42% | 113,497 | - |
| 399 | ARDX | Ardelyx, Inc. | 946.91M | 1.06% | 3,913,784 | 450.89M |
| 400 | ANNX | Annexon, Inc. | 934.63M | 0.82% | 1,842,171 | - |
| 401 | RIGL | Rigel Pharmaceuticals, Inc. | 923.16M | 4.04% | 184,661 | 276.79M |
| 402 | ACRS | Aclaris Therapeutics, Inc. | 909.69M | 2.66% | 1,550,400 | 8.22M |
| 403 | ANL | Adlai Nortye Group Ltd. | 892.23M | 1.65% | 77,707 | 18.06M |
| 404 | SLN | Silence Therapeutics plc | 890.50M | 0.34% | 634,201 | 615.00K |
| 405 | TBPH | Theravance Biopharma, Inc. | 886.25M | 0.23% | 566,894 | 104.31M |
| 406 | BBNX | Beta Bionics, Inc. | 873.47M | 1.81% | 645,038 | 119.01M |
| 407 | HELP | Cybin Inc. | 873.07M | 3.02% | 2,116,648 | - |
| 408 | ACHV | Achieve Life Sciences, Inc. | 872.61M | 2.79% | 1,044,380 | - |
| 409 | HSTM | HealthStream, Inc. | 870.47M | 0.34% | 173,608 | 321.12M |
| 410 | CLYM | Climb Bio, Inc. | 864.42M | 1.55% | 2,214,299 | - |
| 411 | INMD | InMode Ltd. | 859.34M | -0.53% | 412,704 | 374.63M |
| 412 | SIBN | SI-BONE, Inc. | 858.72M | 1.27% | 786,745 | 213.60M |
| 413 | AVR | Anteris Technologies Global Corp. | 837.17M | 1.66% | 470,414 | 2.24M |
| 414 | FDMT | 4D Molecular Therapeutics, Inc. | 825.35M | 4.11% | 1,035,695 | 92.01M |
| 415 | DBVT | DBV Technologies S.A. | 813.62M | 1.42% | 185,679 | 5.04M |
| 416 | CTMX | CytomX Therapeutics, Inc. | 810.59M | 1.36% | 6,489,660 | 18.30M |
| 417 | AHCO | AdaptHealth Corp. | 805.79M | 9.62% | 3,666,492 | 3.36B |
| 418 | GLAS | Glass House Brands Inc. | 805.77M | 0.71% | 660,335 | 176.98M |
| 419 | PHAR | Pharming Group N.V. | 796.14M | 0.81% | 4,987 | 366.48M |
| 420 | CBIO | Crescent Biopharma, Inc. | 793.53M | 3.40% | 214,871 | 11.88M |
| 421 | COLL | Collegium Pharmaceutical, Inc. | 791.10M | 1.25% | 852,655 | 808.21M |
| 422 | MNPR | Monopar Therapeutics Inc. | 780.49M | -1.10% | 203,349 | - |
| 423 | NVCT | Nuvectis Pharma, Inc. | 779.35M | 3.73% | 188,612 | - |
| 424 | VREX | Varex Imaging Corporation | 778.47M | - | 653,579 | 865.00M |
| 425 | AURA | Aura Biosciences, Inc. | 777.79M | 0.94% | 495,493 | - |
| 426 | NGNE | Neurogene Inc. | 767.64M | 1.29% | 252,959 | 925.00K |
| 427 | ASMB | Assembly Biosciences, Inc. | 747.64M | 4.38% | 267,487 | 74.85M |
| 428 | OCS | Oculis Holding AG | 742.02M | -1.31% | 183,064 | 1.45M |
| 429 | PHAT | Phathom Pharmaceuticals, Inc. | 735.52M | -1.38% | 932,633 | 239.66M |
| 430 | OABI | OmniAb, Inc. | 732.77M | 13.51% | 5,084,027 | 38.46M |
| 431 | PHR | Phreesia, Inc. | 732.47M | 0.08% | 759,080 | 507.79M |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 730.42M | 1.99% | 1,347,749 | 136.07M |
| 433 | IRWD | Ironwood Pharmaceuticals, Inc. | 728.71M | 3.28% | 2,432,004 | 389.32M |
| 434 | AHG | Akso Health Group | 728.20M | -5.56% | 12,443 | 13.83M |
| 435 | VSTM | Verastem, Inc. | 726.32M | 5.39% | 5,260,669 | 87.53M |
| 436 | MPLT | MapLight Therapeutics, Inc. | 725.82M | -1.88% | 937,650 | - |
| 437 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 712.75M | 0.79% | 238,878 | - |
| 438 | SOPH | SOPHiA GENETICS SA | 705.71M | -1.60% | 809,618 | 86.17M |
| 439 | STTK | Shattuck Labs, Inc. | 693.51M | 0.58% | 484,425 | 1.00M |
| 440 | DRUG | Bright Minds Biosciences Inc. | 693.29M | 0.40% | 67,012 | - |
| 441 | ALLO | Allogene Therapeutics, Inc. | 684.07M | -0.25% | 5,393,616 | 4.64M |
| 442 | SGMT | Sagimet Biosciences Inc. | 683.12M | 4.67% | 1,800,955 | - |
| 443 | CTEV | Claritev Corporation | 681.80M | 2.24% | 117,648 | 994.67M |
| 444 | SSII | SS Innovations International, Inc. | 681.31M | 1.80% | 68,431 | 52.40M |
| 445 | EVO | Evotec SE | 681.16M | 5.56% | 48,222 | 819.47M |
| 446 | AQST | Aquestive Therapeutics, Inc. | 675.25M | 2.67% | 1,814,473 | 54.09M |
| 447 | GYRE | Gyre Therapeutics, Inc. | 674.37M | -1.70% | 58,060 | 109.82M |
| 448 | AGMB | AgomAb Therapeutics NV | 672.73M | 0.89% | 158,851 | - |
| 449 | CRMD | CorMedix Inc. | 671.10M | 2.74% | 1,100,139 | 462.25M |
| 450 | MDXG | MiMedx Group, Inc. | 663.21M | 0.66% | 1,040,273 | 355.17M |
| 451 | VALN | Valneva SE | 656.63M | 8.37% | 137,178 | 163.30M |
| 452 | PRME | Prime Medicine, Inc. | 652.91M | 2.80% | 2,473,839 | 4.07M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 648.59M | 4.17% | 298,614 | - |
| 454 | ANGO | AngioDynamics, Inc. | 645.61M | -1.51% | 311,373 | 320.17M |
| 455 | ALT | Altimmune, Inc. | 638.02M | 6.15% | 7,472,150 | 31.00K |
| 456 | RGNX | REGENXBIO Inc. | 633.73M | 3.00% | 866,263 | 174.48M |
| 457 | ARVN | Arvinas, Inc. | 627.05M | 3.34% | 548,796 | 316.70M |
| 458 | STLN | Starling Oncology, Inc. | 620.67M | 2.53% | 719,384 | 587.24M |
| 459 | EIKN | Eikon Therapeutics, Inc. | 616.40M | 4.60% | 552,848 | - |
| 460 | TLRY | Tilray Brands, Inc. | 612.98M | 0.44% | 3,219,741 | 915.45M |
| 461 | CTKB | Cytek Biosciences, Inc. | 609.62M | 1.52% | 564,627 | 206.71M |
| 462 | CABA | Cabaletta Bio, Inc. | 605.28M | 8.18% | 7,683,021 | - |
| 463 | EOLS | Evolus, Inc. | 598.42M | -0.22% | 773,922 | 316.49M |
| 464 | AUTL | Autolus Therapeutics plc | 596.20M | -3.03% | 2,307,870 | 117.39M |
| 465 | KIDS | OrthoPediatrics Corp. | 595.30M | -0.87% | 202,883 | 252.72M |
| 466 | TECX | Tectonic Therapeutic, Inc. | 593.91M | -2.69% | 167,347 | - |
| 467 | BLSM | BlossomHill Therapeutics, Inc. | 593.87M | 2.05% | 109,667 | - |
| 468 | WEAV | Weave Communications, Inc. | 584.79M | 0.14% | 5,181,111 | 257.79M |
| 469 | SCTX | Scribe Therapeutics Inc. | 582.91M | 6.55% | 278,606 | 36.28M |
| 470 | SPRY | ARS Pharmaceuticals, Inc. | 578.78M | 0.87% | 1,196,978 | 116.93M |
| 471 | PROK | ProKidney Corp. | 577.44M | 3.24% | 641,215 | 818.00K |
| 472 | DCTH | Delcath Systems, Inc. | 575.31M | 1.10% | 448,596 | 95.42M |
| 473 | CAPR | Capricor Therapeutics, Inc. | 574.99M | -1.20% | 5,165,484 | 11.13M |
| 474 | BWAY | BrainsWay Ltd. | 574.80M | 0.07% | 86,465 | 60.70M |
| 475 | PRLD | Prelude Therapeutics Incorporated | 559.26M | -1.09% | 354,932 | 22.42M |
| 476 | ARTV | Artiva Biotherapeutics, Inc. | 552.95M | 0.27% | 306,517 | 251.00K |
| 477 | FLGT | Fulgent Genetics, Inc. | 551.41M | 2.30% | 412,422 | 323.93M |
| 478 | ZURA | Zura Bio Limited | 543.35M | 0.35% | 617,230 | - |
| 479 | KYTX | Kyverna Therapeutics, Inc. | 532.78M | 3.17% | 599,933 | - |
| 480 | OVID | Ovid Therapeutics Inc. | 529.26M | -1.81% | 1,555,720 | 1.58M |
| 481 | SENS | Senseonics Holdings, Inc. | 525.57M | 5.97% | 820,905 | 48.55M |
| 482 | CERS | Cerus Corporation | 523.96M | -0.38% | 1,572,807 | 221.55M |
| 483 | NPCE | NeuroPace, Inc. | 521.39M | 3.05% | 163,710 | 106.99M |
| 484 | TCMD | Tactile Systems Technology, Inc. | 507.64M | 0.72% | 310,343 | 350.31M |
| 485 | ENTX | Entera Bio Ltd. | 505.57M | 0.69% | 143,496 | 42.00K |
| 486 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 487 | PBYI | Puma Biotechnology, Inc. | 500.20M | 3.64% | 411,913 | 231.24M |
| 488 | PRTA | Prothena Corporation plc | 497.20M | 0.78% | 341,054 | 54.53M |
| 489 | EPRX | Eupraxia Pharmaceuticals Inc. | 490.48M | 17.51% | 749,941 | - |
| 490 | KMDA | Kamada Ltd. | 484.30M | 0.24% | 208,010 | 191.85M |
| 491 | RLMD | Relmada Therapeutics, Inc. | 484.28M | 1.79% | 1,416,550 | - |
| 492 | EVH | Evolent Health, Inc. | 478.24M | -1.17% | 1,503,520 | 2.10B |
| 493 | SRTA | Strata Critical Medical, Inc. | 476.84M | 0.37% | 1,162,334 | 255.98M |
| 494 | RZLT | Rezolute, Inc. | 476.37M | 1.33% | 857,318 | - |
| 495 | ARCT | Arcturus Therapeutics Holdings Inc. | 475.80M | 3.17% | 2,021,096 | 29.37M |
| 496 | DNA | Ginkgo Bioworks Holdings, Inc. | 473.40M | 1.44% | 1,269,747 | 132.42M |
| 497 | EDIT | Editas Medicine, Inc. | 473.03M | 0.33% | 1,677,894 | 47.01M |
| 498 | CCCC | C4 Therapeutics, Inc. | 466.27M | -2.07% | 1,835,364 | 35.04M |
| 499 | SGHT | Sight Sciences, Inc. | 463.84M | 2.81% | 269,379 | 83.38M |
| 500 | AVIR | Atea Pharmaceuticals, Inc. | 457.17M | 3.83% | 289,921 | - |